Floatz logo

(11-L-THREONINE, 29-L-ARGININE)LACTOFERRIN(HUMAN) PRODUCED BY ASPERGILLUS NIGER VAR. AWAMORI

Recurrent Salivary Gland Cancer

Stanford Universityprotein_peptidePhase 1Dormant
CC
43/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
95/ 100

Competitive context

9 Active assets in the Recurrent Salivary Gland Cancer cohort.

Asset / SponsorPhaseRating
Carboplatin
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2BB
TRASTUZUMAB
Genentech, Inc.
Phase 2BB
Cetuximab
Fox Chase Cancer Center
Phase 1/2B
Pembrolizumab
OncoC4, Inc.
Phase 2B
Irinotecan
AIDS Malignancy Consortium
Phase 1/2B

View all 42 →

Same molecule, other indications

(11-L-THREONINE, 29-L-ARGININE)LACTOFERRIN(HUMAN) PRODUCED BY ASPERGILLUS NIGER VAR. AWAMORI is also rated in:

non-small cell lung carcinomaDormant
CCC
Indicative ·
54 / 100
View asset →
head and neck squamous cell carcinomaDormant
CC
Indicative ·
43 / 100
View asset →
metastatic squamous cell carcinomaDormant
CC
Indicative ·
43 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →